Complement inhibitor therapy as a steroid-sparing strategy in generalized myasthenia gravis
CI rapidly and effectively reduced corticosteroid dosage in most AChR-gMG patients, suggesting their potential role as steroid-sparing therapeutic options.
Authors
- Raffaele Iorio (ORCID: https://orcid.org/0000-0003-1599-7096)
- Sofia Marini
- Silvia Falso (ORCID: https://orcid.org/0000-0002-6264-5299)
- Martina Marini
- Federico Habetswallner
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1177/17562864251332037
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Rare Diseases Clinical Research Network
- Ministero della Salute